Use of corticosteroids in asthma and COPD patients with or without COVID-19.
Respir Med
; 170: 106045, 2020.
Article
in English
| MEDLINE | ID: covidwho-378076
ABSTRACT
The potential detrimental effects of steroids on the immune system to fight viral infections had always been a concern for patients on long term steroids in chronic conditions. A recent warning from WHO on systemic corticosteroid use amid COVID-19 raised suspicion among public and healthcare professionals regarding the safety of steroid use during the SARS-CoV-2 pandemic. The corticosteroids (inhaled and oral) are commonly prescribed in the management of asthma and COPD patients and any unsolicited changes in medications use may lead to potentially severe exacerbations and may risk patient lives. This article provides a critical review of clinical evidence and offers a detailed discussion on the safety and efficacy of corticosteroids in asthma and COPD patients, both with and without COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Asthma
/
Coronavirus Infections
/
Pulmonary Disease, Chronic Obstructive
/
Pandemics
/
Glucocorticoids
Type of study:
Observational study
/
Prognostic study
/
Reviews
Limits:
Humans
Language:
English
Journal:
Respir Med
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS